You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤
Overview
In The News
Executives & Employees
Board of Directors
Paths
Owners & Shareholders
Recent Transactions
Transaction Advisors
Financials
Non-Profit Donations & Grants
Suppliers
Competitors

Fennec Pharmaceuticals, Inc.

OVERVIEW

Date Founded
1996
Headquarters
Research Triangle Park, 68 T.w. Alexander Drive, Durham, NC 27709
Type of Company
Public
Employees (Worldwide)
3
Industries
Pharmaceuticals

Biotechnology
Company Description
Fennec Pharmaceuticals, Inc. operates as a small stage biotechnology company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Website

In The News See more

News Bites Canadian Markets
September 22, 2017
News Bites Canadian Markets
September 21, 2017
News Bites Canadian Markets
September 19, 2017
News Bites Canadian Markets
September 18, 2017
News Bites Canadian Markets
September 14, 2017
See full news coverage and complete stories with RelSci Professional.

Executives & Employees See more


Chairman & Chief Executive Officer

Chief Financial Officer

Chief Financial Officer

Head-Regulatory Affairs

Controller

Member, Management Team

Member, Management Team
See our list of current and previous employees when you upgrade.

Board of Directors


Owner at Life Sciences Management GmbH

President at Sigma-Tau Pharmaceuticals, Inc.

Senior Vice President & General Manager-EMEA Region at PTC Therapeutics, Inc.

Former Chairman & Chief Executive Officer at Fennec Pharmaceuticals, Inc.
See our list of current and previous board members when you upgrade.

Paths to Fennec Pharmaceuticals, Inc.

Fennec Pharmaceuticals, Inc.
You
Connections via Relationship Science
Fennec Pharmaceuticals, Inc.
Sync your contacts to see how you can connect with Fennec Pharmaceuticals, Inc..

Owners & Shareholders

Details Hidden
Southpoint Capital Advisors' investment approach can be broadly defined as value-oriented long/short investing. The firm primarily focuses on investments in US corporate equity and debt securities. The Southport Funds' objective is to generate high absolute investment returns, while minimizing the risk of capital loss. The Funds seek to meet this objective by purchasing securities and other financial instruments with trading values substantially below their intrinsic value and selling short securities and other financial instruments with trading values substantially above their intrinsic value.
Details Hidden
Manchester Management Co. LLC is a hedge fund manager located in Boston, Massachusetts.
Details Hidden
683 Capital Management focuses on investments in the stocks of US small-cap companies in the consumer services sector
Details Hidden
Varana Capital LLC is an American private company located in New York, NY, that provides investment advice.
Details Hidden
Varana Capital LLC is an American private company located in New York, NY, that provides investment advice.
See 3 more listings with RelSci Professional.

Recent Transactions

Details Hidden
Fennec Pharmaceuticals, Inc. raised money in a private placement transaction
Details Hidden
Fennec Pharmaceuticals, Inc. raised money in a private placement transaction
Details Hidden
Fennec Pharmaceuticals, Inc. raised money in a private placement transaction
Details Hidden
Fennec Pharmaceuticals, Inc. issued Units
Details Hidden
Fennec Pharmaceuticals, Inc. purchases Cadherin Biomedical Research, Inc.
See 4 more listings with RelSci Professional.

Transaction Advisors

Companies ▾
Legal Advisor
Advised on Fennec Pharmaceuticals, Inc. issued Units
Auditor
Advised on Fennec Pharmaceuticals, Inc. issued Units
Underwriter
Advised on Fennec Pharmaceuticals, Inc. issued Units
Underwriter
Advised on Fennec Pharmaceuticals, Inc. issued Common Stock
Manager
Advised on Fennec Pharmaceuticals, Inc. issued Common Stock
See 2 more listings with RelSci Professional.

Key Stats and Financials as of 2016

Market Capitalization
$220M
Total Enterprise Value
$28.1M
Earnings Per Share
$-0.29
Revenue
$0
Net Profit
$-3.7M
EBITDA
$-3.8M
Total Debt
$0
Total Equity
$4.79M
TEVNet Income
-7.59x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Five Year Compounded Annual Growth Rate Of Revenue
0%
See financial details and more using RelSci Professional.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $50K
2006
Case Western Reserve School of Medicine (CWRU SOM, CaseMed) is one of the graduate schools of Case Western Reserve University, and is located in the University Circle neighborhood of Cleveland, Ohio. The School of Medicine is among the top 25 medical schools in America and is the top-ranked medical school of Ohio in research per U.S. News & World Report.

Suppliers

   Hospitals & Patient Services    Portland, OR
Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. OHSU is the kind of place where the big news doesn't always involve sports, politics, fashion or even weather. The big news is always about health — health care, health education, health-related research. And various organizations and publications that rank American institutions, programs and faculty in a variety of categories have taken note. Nearly one million patient visits each year. Educating thousands of future health care providers. You get the picture. Immerse yourself in more facts and stats than you probably need about Portland's largest employer, Oregon's provider of care to every corner of the state, and one of the nation's top 28 biomedical research institutions. Oregon Health & Science University is the state’s only academic health center. It provides an uncommon array of services from providing the state’s most comprehensive health care, to educating the next generation of clinicians and biomedical researchers, to achieving breakthroughs and innovations.

Competitors

   Pharmaceuticals    New Brunswick, New Jersey
Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. Its baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. It include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
   Biotechnology    Wilmington, DE
Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
   Pharmaceuticals    WASHINGTON, DC
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following business segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
   Pharmaceuticals    Princeton, NJ
Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.
   Pharmaceuticals    Indianapolis, IN
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. It operates through the Human Pharmaceutical Products and Animal Health segments. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing, and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular, and other. The Animal health segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The Other Pharmaceuticals products include anti-infectives, primarily Vancocin and Ceclor, and other miscellaneous pharmaceutical products and services. Its products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
See 9 more listings with RelSci Professional.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial ➤
Still not convinced? Check out our full listing of features here.